{"doi":"10.17615/bhvv-ed21","title":"Association among plasma 1,25(OH)2D, ratio of 1,25(OH)2D to 25(OH)D, and prostate cancer aggressiveness","abstract":"Background: African-American (AA) men tend to present with more aggressive prostate cancer (Gleason score &gt;7) than European-American (EA) men. Vitamin D and its metabolites are implicated in prostate cancer biology with vitamin D deficiency, indicated by its metabolite levels in serum or plasma, usually observed in AA men. Objective: To determine if 1, 25-dihydroxy vitamin D3 [1,25(OH)2D] plasma levels in AA and EA prostate cancer patients alter the risk of having aggressive prostate cancer. Design: Research subjects from the North Carolina-Louisiana Prostate Cancer Project (AA n = 435 and EA n = 532) were included. Plasma metabolites 1,25(OH)2D and 25-hydroxyvitamin D3 [25(OH)D] were measured using liquid chromatography with tandem mass spectrophotometry. Research subjects were classified into low (Gleason sum &lt; 7, stage T1-T2, and Prostate-specific antigen (PSA) &lt; 9 ng/mL) or high (Gleason sum &gt; 8 or Gleason sum = 7 with 4 + 3, or PSA &gt; 20 ng/mL, or Gleason sum = 7 and stage T3-T4) aggressive disease. Results: Research subjects in the second and third tertiles of plasma levels of 1, 25(OH)2D had lower odds of high aggressive prostate cancer (AA [ORT2vsT1: 0.66, 95%CI: 0.39-1.12; ORT3vsT1: 0.83, 95%CI: 0.49-1.41] and EA [ORT2vsT1: 0.68, 95%CI: 0.41-1.11; ORT3vsT1: 0.67, 95%CI: 0.40-1.11]) compared with the first tertile, though confidence intervals included the null. Greater 1,25(OH)2D/25(OH)D molar ratios were associated with lower odds of high aggressive prostate cancer more evidently in AA (ORQ4vsQ1: 0.45, CI: 0.24-0.82) than in EA (ORQ4vsQ1: 0.64, CI: 0.35-1.17) research subjects. Conclusions: The 1,25(OH)2D/25(OH)D molar ratio was associated with decreased risk of high aggressive prostate cancer in AA men, and possibly in EA men. Further studies analyzing vitamin D polymorphisms, vitamin D binding protein levels, and prostatic levels of these metabolites may be useful. These studies may provide a better understanding of the vitamin D pathway and its biological role underlying health disparities in prostate cancer.","journal":"UNC Libraries","year":2023,"id":387351,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":3,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9594,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2023-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":107375,"name":"Elizabeth T. H. Fontham","orcid":null,"position":1,"is_corresponding":false},{"id":294036,"name":"James L. Mohler","orcid":"0000-0002-7726-3795","position":2,"is_corresponding":false},{"id":347018,"name":"Susan E. Steck","orcid":"0000-0002-3201-9537","position":3,"is_corresponding":false},{"id":367196,"name":"Jeannette T. Bensen","orcid":"0000-0003-4972-0087","position":4,"is_corresponding":false},{"id":1156501,"name":"CD Johnson","orcid":null,"position":5,"is_corresponding":false},{"id":1156124,"name":"Swathi Ramakrishnan","orcid":"0000-0001-8352-4704","position":6,"is_corresponding":false},{"id":550277,"name":"Hua Zhang","orcid":"0000-0003-4326-7875","position":7,"is_corresponding":false},{"id":925739,"name":"L. Joseph Su","orcid":"0000-0001-6822-6602","position":8,"is_corresponding":false},{"id":597167,"name":"Lenore Arab","orcid":"0000-0001-8452-7202","position":9,"is_corresponding":false},{"id":367198,"name":"Gary J. Smith","orcid":"0000-0003-1187-4849","position":10,"is_corresponding":false},{"id":594779,"name":"Anna Woloszynska‐Read","orcid":"0000-0001-5279-9414","position":0,"is_corresponding":true}],"reference_count":0,"raw_metadata":null,"created_at":"2026-07-19T01:18:04.706547Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}